Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer

Based on the results of combined data from three North American Phase II studies, a randomised Phase II study in the same patient population was performed, using combination chemotherapy with estramustine phosphate (EMP) and vinblastine (VBL) in hormone refractory prostate cancer patients. In all, 9...

Full description

Saved in:
Bibliographic Details
Main Authors: Albrecht, W, Van Poppel, H, Horenblas, S, Mickisch, G, Horwich, A, Serretta, V, Casetta, G, Maréchal, J M, Jones, W G, Kalman, S, Sylvester, R
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2004
Subjects:
Clinical
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2395315/
https://ncbi.nlm.nih.gov/pubmed/14710214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601468
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items